300750 CONTEMPORARY AMPEREX TECHNOLOGY CO

Hong Kong’s Innovations Radiating Impact at CES 2025


EQS Newswire / 08/01/2025 / 11:00 CET/CEST

Largest-ever delegation of homegrown tech companies capturing global attention and potential business opportunities

HONG KONG SAR - - 8 January 2025 - Hong Kong Science and Technology Parks Corporation (HKSTP) marked significant presence at the Consumer Electronics Show (CES) 2025 in Las Vegas, where a largest-ever delegation of 51 tech companies and institute at Hong Kong Tech Pavilions is capturing the attention of industry leaders, corporate partners and venture capitalists from global markets for business leads and investment opportunities.

HKSTP marked significant presence at the CES 2025, where a largest-ever delegation of 51 tech companies and institute at Hong Kong Tech Pavilions is capturing the attention of industry leaders, corporate partners and venture capitalists from global markets.

Organized in collaboration with the Hong Kong Trade Development Council (HKTDC) and supported by the Hong Kong Electronics Industries Association (HKEIA), the delegation, brought together an array of cutting-edge solutions across advanced electronics, green tech, life & health sciences, and more. Home-grown solutions from HKSTP including smart irrigation system Rocket 2.0 by Full Nature Farms, assistive wearable Seekr by Vidi Labs, and World's smallest 3-axis Micro Gimbal Stabiliser by Vista InnoTech, together with Mobile Ankle-foot Exoneuromusculoskeleton, a telerehabilitation device by The Hong Kong Polytechnic University and Thecon Technology, have been recognised by the CES Innovation Awards 2025.

Albert Wong, CEO of HKSTP, remarked on the overwhelming success, "As an incubator, our ultimate goal lies in advancing the life of humankind. Be it breakthroughs to showcase at premier exhibitions like CES, or bridging between tech and talent with initiatives as Innovation Mixer does, HKSTP has been expanding our global footprint with great momentum in maximising salient achievements and potential opportunities over the years, that promises collaboration and confidence in carrying out our commitment to cultivate the I&T scene."

Part of its broader strategy to enable Hong Kong tech companies to scale globally and endow sustainable impact, HKSTP will be building on the momentum from CES, and continue the Innovation Mixer US expedition in San Francisco to actively engage with ambitious talent; and also in paving way for the second cohort of the Global Booster Programme, catered for stellar tech companies from Hong Kong to embark on an intensive six-month journey in the Silicon Valley to connect with all sorts of resources for technological advancements.
Hashtag: #CES2025

The issuer is solely responsible for the content of this announcement.

About Hong Kong Science and Technology Parks Corporation

Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,000 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.

Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.

Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.

Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong.

More information about HKSTP is available at .

225647
News Source: Hong Kong Science and Technology Parks Corporation

08/01/2025 Dissemination of a Financial Press Release, transmitted by EQS News.
The issuer is solely responsible for the content of this announcement.

Media archive at

fncls.ssp?fn=show_t_gif&application_id=2063629&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
08/01/2025

Underlying

300750CONTEMPORARY AMPEREX TECHNOLOGY CO

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONTEMPORARY AMPEREX TECHNOLOGY CO

 PRESS RELEASE

EQS-News: Dr. Greger & Collegen: Phishing - Die unsichtbare Falle – Si...

Emittent / Herausgeber: Dr. Greger & Collegen / Schlagwort(e): Rechtssache Dr. Greger & Collegen: Phishing - Die unsichtbare Falle – Sind Ihre Daten noch sicher? 09.01.2025 / 15:48 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Phishing - Die unsichtbare Falle – Sind Ihre Daten noch sicher? Auch 2025 schlagen Cyberkriminelle gnadenlos zu: Phishing-Angriffe sind gefährlicher denn je! Täuschend echte E-Mails, manipulierte Webseiten und perfide Tricks zielen darauf ab, Ihre Bankdaten, Passwörter und persönlichen Informationen zu stehlen...

 PRESS RELEASE

EQS-News: BioLizard Welcomes Arjan van Manen as Commercial Director an...

EQS-News: BioLizard nv / Key word(s): Personnel/Conference BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco 09.01.2025 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco   Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciences Meet BioLizard’s Arjan van Manen and CEO Liesbeth Ceelen at Biot...

 PRESS RELEASE

Laxxon Medical Announces Appointment of Two New Members to Board of Di...

Laxxon Medical Announces Appointment of Two New Members to Board of Directors New York, 01/09/2025 / 09:00, EST/EDT - EQS Newswire - Laxxon Medical Laxxon Medical, a leader in pharmaceutical drug delivery, announced today the appointment of new independent directors to its Board of Directors: Christof Bircher and Nneka Ukpai."We are excited to welcome both Christof Bircher and Nneka Ukpai to Laxxon's Board of Directors," said Helmut Kerschbaumer, Laxxon CEO and Chairman of the Board. "Both will bring extensive experience in business strategy, corporate finance and technology development, h...

 PRESS RELEASE

EQS-News: Bryan Garnier & Co berät PPM-Softwareanbieter collaboration ...

Emittent / Herausgeber: Bryan, Garnier & Co. / Schlagwort(e): Beteiligung/Unternehmensbeteiligung/Firmenübernahme Bryan Garnier & Co berät PPM-Softwareanbieter collaboration Factory (cplace) bei der Mehrheitsübernahme durch Level Equity / europäische Softwareunternehmen zunehmend im Fokus von US-Finanzinvestoren 09.01.2025 / 13:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bryan Garnier & Co. berät PPM-Softwareanbieter collaboration Factory (cplace) bei Mehrheitsübernahme durch Level Equity / europäische Softwareunternehmen zune...

 PRESS RELEASE

EQS-News: Assessing Post-Cardiac Surgery Kidney Recovery Through PenKi...

Issuer: SphingoTec GmbH / Key word(s): Research Update/Scientific publication Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid's Emerging Role in Renal Replacement Therapy Decisions 09.01.2025 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Proenkephalin A 119-159 (penKid) demonstrates potential as a predictor for successful discontinuation of continuous renal replacement therapy (CRRT) in cardiac surgery patients. Study reveals significant differences in penKid levels between patients successfully and unsuccessfully l...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch